A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
10/2006
10/26/2006	WO2006113666A2 Amphiphilic polymers and methods of use thereof
10/26/2006	WO2006113089A2 Diagnosis by determination of hyperactivity or increased expression of members of cell signaling pathways
10/26/2006	US20060241018 Linkers for radiopharmaceutical compounds
10/26/2006	US20060239923 Gastrin releasing peptide compounds
10/26/2006	US20060239915 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases
10/26/2006	US20060239914 bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy
10/26/2006	US20060239913 Peptide conjugate for magnetic resonance imaging
10/26/2006	US20060239912 Carrier molecules
10/26/2006	US20060239911 Antibodies with immune effector activity and that internalize in endosialin-positive cells
10/26/2006	US20060239910 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
10/26/2006	US20060239909 Treatment of protein degradation disorders
10/26/2006	US20060239908 Compositions for inhalation
10/26/2006	US20060239907 Stealthy nano agents
10/26/2006	CA2649391A1 Method and apparatus for kidney function analysis
10/26/2006	CA2606270A1 Amphiphilic polymers and methods of use thereof
10/26/2006	CA2606136A1 Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test
10/25/2006	EP1713516A2 Method and kit for the production of particles labelled with rhenium-188
10/25/2006	EP1713515A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
10/25/2006	EP1713513A2 Cellular labeling for nuclear magnetic resonance techniques
10/25/2006	EP1713512A2 Contrast agents for myocardial perfusion imaging
10/25/2006	EP1713457A2 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
10/25/2006	EP1558293A4 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
10/25/2006	EP1534990B1 Automated dynamic pressure-responsive hyperpolarized gas dispensing systems, and associated methods and computer program products
10/25/2006	EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006	EP1135170B1 Radioconjugation of internalizing antibodies
10/25/2006	CN1852742A Somatostatin analogs with inhibitory activity to growth hormone release
10/24/2006	US7126004 Thiazoline acid derivatives
10/24/2006	US7125965 an spiro(1-benzopyran-2,2'-indole) indicator coupled to a lanthanide-chelated DO3A macrocycle; conformational changes of the indicator affect the interaction of the bound lanthanide with water
10/24/2006	US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization
10/24/2006	US7125683 Preparations for diagnosis extrapancreatic secretory function
10/24/2006	US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker
10/24/2006	CA2273549C Diagnostic agents for pancreatic exocrine function
10/24/2006	CA2212744C Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
10/19/2006	WO2006110745A2 Conjugated anti-psma antibodies
10/19/2006	WO2006110172A2 Steroid analogs and characterization and treatment methods
10/19/2006	WO2005094327A9 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060233708 Peptide antagonists of TGF-beta family members and therapeutic uses thereof
10/19/2006	US20060233707 Process for producing an injectable medicament preparation
10/19/2006	US20060233706 Marked peptides having affinity for a phospholipid and uses
10/19/2006	US20060233705 Diagnosis by determination of hyperactivity or increased expression of members of cell signaling pathways
10/19/2006	US20060233704 Prochelator for the preparation of radiometal labeled molecules having improved biological properties
10/19/2006	DE102005016956A1 Aktivierbares Implantat, insbesondere Seed Activatable implant, in particular Seed
10/18/2006	EP1523337B1 Imaging method and device for carrying out said method
10/18/2006	EP0806968B1 Diagnostic imaging contrast agents with extended blood retention
10/18/2006	EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/18/2006	CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1
10/18/2006	CN1849144A Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ED-B
10/18/2006	CN1849143A Method of treating angiogenic tissue growth
10/18/2006	CN1279907C Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122202 Pre-formed liposomes having entrapped therapeutic agent and targeting conjugates composed of a lipid, hydrophilic polymer, and a targeting ligand such as an antibody
10/12/2006	WO2006108167A1 Bioactive stents for type ii diabetics and methods for use thereof
10/12/2006	WO2006107786A2 Improved stably tethered structures of defined compositions with multiple functions or binding specificities
10/12/2006	WO2006107106A1 Ligand for vesicular acetylcholine transporter
10/12/2006	WO2006107098A1 Glycerol ester derivative having metal chelate structure
10/12/2006	WO2006105936A1 Integrated pharmaceutical production, quality assurance, and safety system (iqs)
10/12/2006	WO2006063418A3 Nanostructure radioactif
10/12/2006	WO2005107763A3 Radiopharmaceutical and methods of synthesis and use thereof
10/12/2006	US20060228300 Fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications
10/12/2006	US20060228299 Constructs binding to phosphatidylserine and their use in disease treatment
10/12/2006	US20060228298 Imaging and selective retention of phospholipid ether analogs
10/12/2006	US20060228297 Thorium-227 for use in radiotherapy of soft tissue disease
10/12/2006	US20060228296 Method of screening groups of radioactive molecules and applications thereof
10/12/2006	DE102004057225B4 Verfahren und Vorrichtung zur Isolierung eines chemisch und radiochemisch gereinigten 68Ga-Radionuklids und zum Markieren eines Markierungsvorläufers mit dem 68Ga-Radionuklid Method and apparatus for isolating a chemically and radiochemically purified 68 Ga radionuclide and for marking a labeling precursor with the radionuclide 68Ga
10/12/2006	CA2604034A1 Improved stably tethered structures of defined compositions with multiple functions or binding specificities
10/12/2006	CA2603437A1 Poly(peptide) as a chelator: methods of manufacture and uses
10/12/2006	CA2602090A1 Bioactive stents for type ii diabetics and methods for use thereof
10/11/2006	EP1708758A2 System and method for expression proteomics based on isotope ratio modification
10/11/2006	EP1708750A1 Targeting of erb antigens
10/11/2006	EP1708688A2 Non-invasive system for detecting skin cancer
10/11/2006	EP0668777B1 Prostate-specific membrane antigen
10/10/2006	US7119069 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
10/10/2006	US7118919 Glucose for analysis of diabetes, Insulin resistance and metabolism
10/10/2006	US7118749 Transferrin receptor genes
10/10/2006	US7118731 Antitumor agents; anticancer agents; viricides; nucleoside derivative
10/10/2006	US7118730 Quinoline derivative as diagnostic probe for disease with tau protein accumulation
10/10/2006	US7118729 Radioactive source materials formable into various shapes
10/10/2006	CA2276284C Radioiodinated phospholipid ether analogs and methods of using the same
10/05/2006	WO2006105234A2 Hybrid inorganic nanoparticles, methods of using and methods of making
10/05/2006	WO2006103509A2 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via ketene using diazo compounds and carbon-isotope monoxide
10/05/2006	WO2006102759A1 Novel substituted 2-nitroimidazoles useful for hypoxic cell therapy and imaging
10/05/2006	WO2006102716A1 A method of diagnosis and treatment and agents useful for same
10/05/2006	WO2006082108A3 Imaging method and composition for imaging vascular diseases
10/05/2006	WO2006071138A8 Tritium-traced saxitoxin dihydrochloride and method for the production thereof
10/05/2006	WO2006047372A9 Lamotrigine analogs
10/05/2006	WO2003074652A3 Methods for identifying agents that modulate mast cell degranulation
10/05/2006	US20060222593 Peptide-chelate conjugates
10/05/2006	US20060222588 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent
10/05/2006	US20060222587 Hybrid inorganic nanoparticles, methods of using and methods of making
10/05/2006	CA2602385A1 Hybrid inorganic nanoparticles, methods of using and methods of making
10/05/2006	CA2602122A1 A method of diagnosis and treatment and agents useful for same
10/04/2006	EP1707219A2 Radioactive kits for a gastric emptying measurement
10/04/2006	EP1706155A1 Polymeric micellar complexes and drug delivery vehicles thereof
10/04/2006	EP1706154A1 Improved gastrin releasing peptide compounds
10/04/2006	EP1706145A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment
10/03/2006	US7115766 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
10/03/2006	US7115720 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain)
10/03/2006	US7115708 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors
10/03/2006	US7115249 producing radiolabelled 6-L-fluorodopa on support; deblocking, deprotecting; for use in positron emission tomography; kits

1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 243